Meta Wants Sell Compute: A New Rival to AWS and Google Cloud
Meta Platforms signals a cloud compute push, aiming to sell AI capacity directly to enterprises amid a record capex c...
Yearly Tax Harvesting Strategy Index Funds
A yearly strategy formalizes harvest windows, helping you optimize tax outcomes while staying invested in index funds.
22,166 articles
Larry Ellison Once World’s Richest, Oracle Slumps Amid Empire Fight
Oracle shares slide as Larry Ellison funds a bid to steer a $110 billion media empire, triggering regulatory hurdles ...
Here's Materials Continues to Soar: MP Materials in 2026
MP Materials is catching investor attention again in 2026 as policy support, domestic production efforts, and a risin...
Dominion Energy 2025 Earnings: A Clear Look for Investors
Dominion Energy 2025 earnings shaped the 2026 outlook. This analysis breaks down the Q4 results, key drivers, and wha...
Tesla Stock's Bold Strategic Shift Opens Opportunity
Tesla is signaling a bold move beyond traditional EVs. This article examines tesla stock's bold strategic shift, what...
This Transportation Stock Outperform in 2026: A Play
One transportation stock could outpace the S&P 500 in 2026 thanks to rising freight volumes, pricing power, and stron...
How to Build $3,000 a Month in Dividend Income Today
A year-by-year calculation shows how much capital you need to generate $3,000 a month via dividends, with tradeoffs a...
B&G Foods: Foods (BGS) 2026 Earnings Outlook and Guide
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
$500? Dirt-Cheap Dividend Powerhouse Under $5 to Buy
As volatility eases, income-focused investors eye a dirt-cheap dividend powerhouse trading under $5. The article expl...
67-Year-Old Retiree’s $1.9 Million Plan Survives Market Drop
A 67-year-old retiree’s $1.9 million portfolio shed 21% during a broad market pullback, yet a cash-and-Treasury ladde...
Spacemobile Stock Crashed Today: What Investors Should Do
A sharp intraday drop and quick questions about the company’s outlook have many traders rethinking positions. This gu...
AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status